WHAT ELSE APART FROM AUTISM?

[Guest guest]

WHAT ELSE APART FROM AUTISM? Nearly 20 years ago in 1989 a British Chemist, Barry realised that nearly 1 500 deaths each year in the United Kingdom were completely explainable. Barry had spent 500 000 pounds of his own money to check out the chemistry of his idea. He wrote a paper and submitted to the British Medical Journal. He contacted the Government. He contacted University Chemists. He contacted the medical experts. He had a TOXIC theory of Cot Death (SIDS). The theory made complete sense.The theory matched the toxic conditions that babies were exposed to.The other theories were a shambles and obvious cover up. Barry had a serious problem. He was not part of the establishment. He was not party to the inner thinkings of the Government, Industry or Universities. He was no doctor. He did not get a letter of congratulation from the Government.He did not get a letter of congratulation from the Chief Medical Officer of the UKHe did not get a letter of congratulation from the UK Foundation for Sudden Infant Death. In short his theory of a TOXIC cause of cot death was as welcome as Sudden Death to a bereaved family. WHY? WHY? WHY? The fact was that the Government already knew! They knew more than 10 years before that the exact, same, brain nerve destroying chemical family had been found guilty of killing specifically babies of the age from 0 to 6 months of age in USA and the UK. In fact, the chemical in question was in such short supply (to kill?) that it was not allowed for any other age of person only for toxifying little babies under 6 months of age. Now another unknown chemist again found the same family of brain destroying chemicals guilty of killing children 10 years after the first unknown chemist? Very embarrassing or not? The Government could hardly respond in the same way as the first time and get the work confirmed and remove the brain destroying chemical from doing its deadly work. That would admit it had been asleep at the wheel for a decade. No, heads would roll. They used first dense fog. Then they used deliberate smokescreens. Then they discovered a flaw not in the manner that Government and Industry approved brain destroying chemicals were killing children but a flaw in the pharmokinetics of the death of children proposed by Barry. They destroyed him not because he was wrong but because he had made a wrong guess in the chemical pathway to the death of the children. Today you will find your babies mattresses with this curious sticker: This child’s mattress contains NO antimony arsenic or phosphorus. The 3 elements that US government? US scientists and US pharma had known years ago were killing babies but that by some mischance, oversight and incompetence had all left in every babies mattress for another ten years still killing and even making Government think their withdrawal of toxic elements was hasty, not necessary and certainly hadn’t harmed our babies. The ‘Survival of the Fittest’ had been going on for more than ten years when the bombshell of Barry and his certain knowledge came through their letter boxes. Not only had the original toxin being killing but the removal had not gone ‘According to Plan’. Government, scientists and pharma are not silly stupid or unlearning. In 1997 when Professor Wetterhahn dropped dead from an almost zero amount of mercury on her protected gloved hand, it prompted a furore of activity and a COMPLETE survey of everything containing MERCURY that was exposed to children in their first year of life. Today we know the full result of that survey, the imaginary withdrawal from babies vaccines, the lack of acceptance by government, industry and pharma. We see the rising autism rates in the US. We see the worldwide export of mercury vaccines around the world. We see a war where babies are dying, people are in denial and the war is taken to those families by false accusation, false testimony and false imprisonment. Today we see in the Canadian awareness of the situation and the recommendation that the thousands imprisoned stay there because ‘science’ is like fashion and may change. Those wrongly condemned in Canada may after all be ‘guilty’. TOXIC elements like arsenic, antimony and mercury may not be killing our children after all. Perhaps a million parents are brutally killing their own babies after spending fortunes on them and mysteriosuly killing them, leaving no trace of how they did it and just the 100 or so clinical signs that they had succumbed to arsenic, antimony and MERCURY poisoning. These EVIL, EVIL, EVIL parents. And so cunning at disguising the way they brutally and mercilessly kill their babies they love! Oh yes! I almost forgot. Barry’s paper 20 years ago was returned to him. Sorry Barry, we can’t publish your paper not because it has a poor scientific evidence but it has a ZERO political respectibility, credibility or reality. Signed by a Knight (UK) of the realm. Does this explain why we have a Sir Southall who tried to save childrens lives by depriving them of oxygen? And does this explain how an unknown doctor (Roy Meadow) gave more than twice the lethal dose of another element to a baby and went on to get a knighthood too? “Barry! You lack political respectibility, credibility and reality. You lost 500 000 pounds. If you get political respectibility, credibility and reality. We pay you the 500 000 pounds. We give you a knighthood. And everybody is happy?” EVER BEEN HAD! I think the people here on this site are disrespectable, uncredible and unreal. Demonstration that’s the only way out of this impasse. If we can’t learn TOXIC means TOXIC, what can we learn? SIDS is another catastrophe going unanswered by those who pay themselves, honour themselves, and protect themselves. But what the XXXX are they doing to the members of this group, parents of children and the rest of the worlds families? Why don’t we just: BAN MERCURY WORLWIDE FROM VACCINES And not repeat the errors made for arsenic, antimony and phosphorus?

[Guest guest]

, Who exactly were you referring to in this comment?: "Today we see in the Canadian awareness of the situation and the recommendation that the thousands imprisoned stay there because ‘science’ is like fashion and may change. Those wrongly condemned in Canada may after all be ‘guilty’." Here in Ontario, Canada, we also had a doctor who gave (erroneous) evidence, which ended up in likely innocent parents being imprisoned. Are you referring to him, or something/someone else? The bit about antimony is interesting. Today, I finally came across Frustaci's study, which showed that the sufferers of idiopathic dilated cardiomyopathy they looked at had very high levels of mercury and antimony in their myocardial samples. Where could these high levels of antimony and mercury have come from? Lorscheider and Vimy did ask Frustaci to look at their subjects' dental amalgams, but Frustaci replied that the mercury did not likely come from the dental amalgams. I'll paste one of the links I came across today, below, and hope to attach the others above. Aasa http://www.csulb.edu/~druz/wesconemb/BioImmune.pdf johnfryer@... wrote: WHAT ELSE APART FROM AUTISM? Nearly 20 years ago in 1989 a British Chemist, Barry realised that nearly 1 500 deaths each year in the United Kingdom were completely

explainable. Barry had spent 500 000 pounds of his own money to check out the chemistry of his idea. He wrote a paper and submitted to the British Medical Journal. He contacted the Government. He contacted University Chemists. He contacted the medical experts. He had a TOXIC theory of Cot Death (SIDS). The theory made complete sense. The theory matched the toxic conditions that babies were exposed to. The

other theories were a shambles and obvious cover up. Barry had a serious problem. He was not part of the establishment. He was not party to the inner thinkings of the Government, Industry or Universities. He was no doctor. He did not get a letter of congratulation from the Government. He did not get a letter of congratulation from the Chief Medical Officer of the UK He did not get a letter of congratulation from

the UK Foundation for Sudden Infant Death. In short his theory of a TOXIC cause of cot death was as welcome as Sudden Death to a bereaved family. WHY? WHY? WHY? The fact was that the Government already knew! They knew more than 10

years before that the exact, same, brain nerve destroying chemical family had been found guilty of killing specifically babies of the age from 0 to 6 months of age in USA and the UK. In fact, the chemical in question was in such short supply (to kill?) that it was not allowed for any other age of person only for toxifying little babies under 6 months of age. Now another unknown chemist again found the same family of brain destroying chemicals guilty of killing children 10 years after the first unknown chemist? Very embarrassing or not? The Government could hardly respond in the same way as the first time

and get the work confirmed and remove the brain destroying chemical from doing its deadly work. That would admit it had been asleep at the wheel for a decade. No, heads would roll. They used first dense fog. Then they used deliberate smokescreens. Then they discovered a flaw not in the manner that Government and Industry approved brain destroying chemicals were killing children but a flaw in the pharmokinetics of the death of children proposed by Barry. They destroyed him not because he was wrong but because he had made a wrong guess in the chemical pathway to the death of the

children. Today you will find your babies mattresses with this curious sticker: This child’s mattress contains NO antimony arsenic or phosphorus. The 3 elements that US government? US scientists and US pharma had known years ago were killing babies but that by some mischance, oversight and incompetence had all left in every babies mattress for another ten years still killing and even making Government think their

withdrawal of toxic elements was hasty, not necessary and certainly hadn’t harmed our babies. The ‘Survival of the Fittest’ had been going on for more than ten years when the bombshell of Barry and his certain knowledge came through their letter boxes. Not only had the original toxin being killing but the removal had not gone ‘According to Plan’. Government, scientists and pharma are not silly stupid or unlearning. In 1997 when Professor Wetterhahn dropped dead from an almost zero amount of mercury on her protected gloved hand, it prompted a furore of activity and a COMPLETE survey of everything containing MERCURY that was exposed to children in their first year of life. Today we know the full result of that survey, the imaginary withdrawal from babies vaccines, the lack of acceptance by government, industry and pharma. We see the rising autism rates in the US. We see the worldwide export of mercury vaccines around the world. We see a war where babies are dying, people are in denial and the war is taken to those families by false accusation, false testimony and false imprisonment. Today we see in the Canadian awareness of the situation and the recommendation that the thousands imprisoned stay there because ‘science’ is like fashion and may change. Those wrongly condemned in Canada may after all be ‘guilty’. TOXIC elements like arsenic, antimony and mercury may not be killing our children after all. Perhaps a million parents are brutally killing their own babies after spending fortunes on them and mysteriosuly killing them, leaving no trace of how they did it and just the 100 or so clinical signs that they had succumbed to arsenic, antimony and MERCURY poisoning. These EVIL, EVIL, EVIL parents. And so cunning at disguising the way they brutally and mercilessly kill their babies they

love! Oh yes! I almost forgot. Barry’s paper 20 years ago was returned to him. Sorry Barry, we can’t publish your paper not because it has a poor scientific evidence but it has a ZERO political respectibility, credibility or reality. Signed by a Knight (UK) of the realm. Does this explain why we have a Sir Southall who tried to save childrens lives by depriving them of oxygen? And does this explain how an unknown doctor (Roy Meadow) gave more than twice the lethal dose of another element to a baby and went on to get a knighthood too? “Barry! You lack political respectibility, credibility and

reality. You lost 500 000 pounds. If you get political respectibility, credibility and reality. We pay you the 500 000 pounds. We give you a knighthood. And everybody is happy?” EVER BEEN HAD! I think the people here on this site are disrespectable, uncredible and unreal. Demonstration that’s the only way out of this impasse. If we can’t learn TOXIC means TOXIC, what can we learn? SIDS is another catastrophe going unanswered by those who pay themselves, honour themselves, and protect themselves. But what the XXXX are they doing to the members of this group, parents of children and the rest of the worlds families? Why don’t we just: BAN MERCURY WORLWIDE FROM VACCINES And not repeat the errors made for arsenic, antimony and phosphorus?



Athens/Institution Login

Not Registered?

User Name:

Password:

Remember me on this computer

Forgotten password?

Home

Browse

My Settings

Alerts

Help

Quick Search

Title, abstract, keywords

Author

e.g. j s smith

Journal/book title

Volume

Issue

Page

Journal of the American College of Cardiology Volume 33, Issue 6, May 1999, Pages 1578-1583

SummaryPlus

Full Text + Links

PDF (171 K)

View thumbnail images | View full size images

Related Articles in ScienceDirect

Trace elements linked to cardiomyopathyThe Lancet

Trace elements linked to cardiomyopathyThe Lancet, Volume 353, Issue 9164, 8 May 1999, Page 1594Larry HustenAbstract | Full Text + Links | PDF (68 K)

Improvement of Left Ventricular Dyssynchrony by Carvedi...Journal of Cardiac Failure

Improvement of Left Ventricular Dyssynchrony by Carvedilol Therapy in Patients with Idiopathic Dilated Cardiomyopathy: Analysis Using Strain EchocardiographyJournal of Cardiac Failure, Volume 11, Issue 9, Supplement 1, December 2005, Page S301Yasuhiko Takemoto, Takeshi Hozumi, Kenichi Sugioka, Yoshiki Matsumura, Yasuhiro Takagi, Keiji Ujino, Minoru Yoshiyama and Junichi YoshikawaPDF (75 K)

Long-term outcome of patients with biopsy-proved myocar...Journal of the American College of Cardiology

Long-term outcome of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, Volume 26, Issue 1, July 1995, Pages 80-84Martha Grogan, Margaret M. Redfield, Kent R. , Guy S. er, Bernard J. Gersh, D. and J. RodehefferAbstract

Objectives.The study objectives were 1) to assess the long-term outcome of patients with biopsy-proved lymphocytic myocarditis (Dallas criteria), and 2) to compare the outcome of these patients with that of patients with idiopathic dilated cardiomyopathy.

Background.

Endomyocardial biopsy is frequently performed in patients presenting with dilated cardiomyopathy to identify lymphocytic myocarditis. Most previous studies of the natural history of myocarditis were performed before the establishment of the Dallas criteria. Thus, it is important to evaluate the prognostic value of positive endomyocardial biopsy findings in patients presenting with dilated cardiomyopathy, using standardized criteria for lymphocytic myocarditis.

Methods.

All endomyocardial biopsy results from the Mayo Clinic (October 1979 to April 1988) with a diagnosis of myocarditis were reclassified according to the Dallas criteria. Patients whose biopsy specimens showed borderline or lymphocytic myocarditis were included in the study group; those with systemic inflammatory diseases known to be associated with myocardial involvement were excluded. Study group survival was compared with that for a cohort of patients with idiopathic dilated cardiomyopathy seen at the Mayo Clinic from 1976 to 1987 who had endomyocardial biopsy findings negative for myocarditis.

Results.

Biopsy specimens from 41 patients met the Dallas criteria for a diagnosis of myocarditis (n = 28) or borderline myocarditis (n = 13). Of these 41 patients, 9 were excluded because of the presence of systemic diseases known to be associated with myocarditis, and 5 patients were excluded because of lack of available follow-up data. The myocarditis study group therefore included 27 patients (10 with borderline myocarditis, 17 with myocarditis). Fifty-eight patients with a diagnosis of idiopathic dilated cardiomyopathy who underwent endomyocardial biopsy served as the comparison cohort. Ejection fraction was lower in patients with idiopathic dilated cardiomyopathy ([mean ± SD] 25 ± 11%) than in those with myocarditis (38 ± 19%, p = 0.001), even though a higher proportion of myocarditis group patients were in New York Heart Association functional class III or IV (63%) than patients in the dilated cardiomyopathy group (30%, p = 0.005). There was no difference in 5-year survival rate between the myocarditis and idiopathic dilated cardiomyopathy groups (56% vs. 54%, respectively).

Conclusions.

This study demonstrates that the long-term outcome of patients with biopsy-proved myocarditis seen in a referral setting is poor, although no different from that of patients with idiopathic dilated cardiomyopathy. With the current lack of proved effective treatment for lymphocytic myocarditis and no demonstration of survival benefit for patients with myocarditis, these data suggest that endomyocardial biopsy performed to exclude myocarditis is of limited prognostic value in the routine evaluation of dilated cardiomyopathy.Abstract | Abstract + References | PDF (527 K)

301 Withdrawn Evaluation of mechanical dyssynchrony in ...European Journal of Heart Failure Supplements

301 Withdrawn Evaluation of mechanical dyssynchrony in dilated cardiomyopathy: Idiopathic versus noncompaction of left ventricleEuropean Journal of Heart Failure Supplements, Volume 5, Issue 1, 2006, Pages 70-71M. Moshkani Farahani, M. Esmaeil Zadeh and A. Bagher ZadehPDF (270 K)

Lack of T Cell Response to Cardiac Myosin and a Reduced...Journal of Autoimmunity

Lack of T Cell Response to Cardiac Myosin and a Reduced Response to PPD in Patients with Idiopathic Dilated CardiomyopathyJournal of Autoimmunity, Volume 10, Issue 2, April 1997, Pages 219-227K. V. Bromelow, B. Souberbielle, A. Alavi, J. H. Goldman, L. D. Libera, A. G. Dalgleish and W. J. McKennaAbstract

Idiopathic dilated cardiomyopathy (IDCM) is the main cause of cardiac transplantation in young adults in the 20–40 years age group in the Western world. Recent evidence supports a possible role for autoimmune pathogenesis in IDCM and it has been suggested that T cells could mediate the disease. Cardiac myosin is one of the putative autoantigens recognized by antibodies from patients with IDCM, but T cell responses to cardiac myosin have not previously been assessed. Proliferation to cardiac myosin by peripheral blood mononuclear cells (PBMC) from patients, their relatives and controls was assessed in a lymphoproliferation assay specifically designed to measure low frequency T cell precursor responses. The study group consisted of 23 patients with IDCM and 29 relatives. The control groups consisted of 10 patients with heart failure secondary to ischaemic heart disease (IHD) and 22 healthy laboratory controls. A response to myosin was observed in 16.7% of the subjects studied. However, these responses were all of low precursor frequency and no dose response for antigen-specific proliferation could be observed. More importantly, there was no correlation between myosin-specific T cell responses and IDCM, as only one IDCM patient and four IDCM relatives (three out of the four with left ventricular enlargement (LVE)) were among the 14 subjects whose PBMC exhibited a proliferative response. However, proliferation of PBMC to purified protein derivative of Mycobacterium bovis (PPD) was significantly suppressed in IDCM patients when compared with the laboratory control group (P<0.05). PPD response data suggested that the PPD suppression correlated with disease progression. The results of our present study indicate an absence, or lack, of cardiac myosin-specific peripheral blood T cells in IDCM patients, along with the possibility of underlying impaired cell mediated immunity, reflected in the suppressed responses to PPD. Future studies looking at T cell immune mechanisms in IDCM should concentrate on the analysis of T cells from the heart itself, or look at other potential cardiac antigens from normal and diseased heart tissue.Abstract | PDF (176 K)

View More Related Articles

View Record in Scopus

Cited By in Scopus (21)doi:10.1016/S0735-1097(99)00062-5 Copyright © 1999 American College of Cardiology. Published by Elsevier Science Inc.

Clinical Studies

Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction

Frustaci MD, *, Nicola Magnavita MD†, Cristina Chimenti MD*, Marina Caldarulo MD†, Enrico Sabbioni PhD‡, Romano Pietra PhD‡, Carlo Cellini MD§, Gian Federico Possati MD§ and Attilio Maseri MD* * Department of Cardiology, Catholic University, Rome, Italy† Department of Occupational Medicine, Catholic University, Rome, Italy§ Department of Cardiac Surgery, Catholic University, Rome, Italy‡ CEC Environmental Institute Joint Research Center Ispra (VA), Rome, Italy Received 8 June 1998; revised 11 January 1999; accepted 21 January 1999. Available online 29 April 1999.

Abstract

OBJECTIVES

We sought to investigate the possible pathogenetic role of myocardial trace elements (TE) in patients with various forms of cardiac failure.

BACKGROUND

Both myocardial TE accumulation and deficiency have been associated with the development of heart failure indistinguishable from an idiopathic dilated cardiomyopathy.

METHODS

Myocardial and muscular content of 32 TE has been assessed in biopsy samples of 13 patients (pts) with clinical, hemodynamic and histologic diagnosis of idiopathic dilated cardiomyopathy (IDCM), all without past or current exposure to TE. One muscular and one left ventricular (LV) endomyocardial specimen from each patient, drawn with metal contamination-free technique, were analyzed by neutron activation analysis and compared with 1) similar surgical samples from patients with valvular (12 pts) and ischemic (13 pts) heart disease comparable for age and degree of LV dysfunction; 2) papillary and skeletal muscle surgical biopsies from 10 pts with mitral stenosis and normal LV function, and 3) LV endomyocardial biopsies from four normal subjects.

RESULTS

A large increase (>10,000 times for mercury and antimony) of TE concentration has been observed in myocardial but not in muscular samples in all pts with IDCM. Patients with secondary cardiac dysfunction had mild increase (≤5 times) of myocardial TE and normal muscular TE. In particular, in pts with IDCM mean mercury concentration was 22,000 times (178,400 ng/g vs. 8 ng/g), antimony 12,000 times (19,260 ng/g vs. 1.5 ng/g), gold 11 times (26 ng/g vs. 2.3 ng/g), chromium 13 times (2,300 ng/g vs. 177 ng/g) and cobalt 4 times (86,5 ng/g vs. 20 ng/g) higher than in control subjects.

CONCLUSIONS

A large, significant increase of myocardial TE is present in IDCM but not in secondary cardiac dysfunction. The increased concentration of TE in pts with IDCM may adversely affect mitochondrial activity and myocardial metabolism and worsen cellular function.

Abbreviations: Ag, silver; As, arsenic; Ca, calcium; Hg, mercury; IDCM, idiopathic dilated cardiomyopathy; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; pts, patients; Sb, antimony; TE, trace elements

Article Outline

• Methods

• Patient population

• Trace elements assessment

• Statistical analysis

• Results

• Clinical study

• Myocardial and muscle TE concentration

• Discussion

• Consideration on TE assessment

• Preanalytic factors on TE assessment

• Side of myocardial TE increase

• Trace elements and ventricular arrhythmias

• Trace elements in IDCM compared with secondary cardiac dysfunction

• Possible mechanism of TE accumulation in IDCM

• Potential consequences of TE accumulation in IDCM

• Conclusions

• References

Idiopathic dilated cardiomyopathy (IDCM) is, by definition, a disease characterized by dilation and impaired contraction of the left or both ventricles. Its etiology is still unknown and the pathogenetic mechanism debated, although a viral and/or immune, genetic/familial or toxic mechanism has been suggested [1, 2, 3, 4, 5, 6, 7 and 8].

Trace elements (TE) are known to have a key role in myocardial metabolism and both TE accumulation (cobalt, arsenic) and deficiency (selenium, i.e., Keshan disease) may be responsible for a dilated cardiomyopathy indistinguishable from an idiopathic form [9 and 10]. It has been documented that even a sackie viral infection can cause a great TE accumulation in the mouse heart [11 and 12].

To investigate the possible pathogenetic role of TE in IDCM, 32 TE were assessed by neutron activation analysis in left ventricular (LV) endomyocardial and muscular biopsy specimens from patients with IDCM and specific forms of cardiac dysfunction.

Methods

Patient population

Thirteen patients (9 male, 4 female, mean age 50.9 ± 10.1 years) with IDCM (group A) were included in the study (Table 1). The patients were admitted to our institution because of dyspnea (New York Heart Association class II–IV) and palpitation. No patients had hypertension, drug or alcohol abuse, ischemic heart disease or systemic disorders. All patients underwent noninvasive (electrocardiography, two-dimensional echocardiography and Holter monitoring) and invasive (cardiac catheterization, coronary arteriography and left ventricular endomyocardial biopsy) cardiac studies. Endomyocardial biopsies were performed in the septal–apical region of left ventricle, which was approached by a 7-F (501-613A Cordis) long sheet and identified on an X-ray view using flashing of contrast medium (iohexol, Omnipaque, Nycomed). Three to four left ventricular samples were drawn, processed for histology and electron microscopy and read by a pathologist blinded to the clinical data. Specifically, the tissue specimens for light microscopy were fixed in 10% buffered formaline, and embedded in paraffin wax; 5-μm thick sections were cut and stained with hematoxylin–eosin, ’s elastic Van Gieson and Masson’s trichrome. For electron microscopy all samples of myocardial tissue were fixed in a solution of 2% glutaraldehyde in a 0.1 mol/L phosphate buffer, at pH 7.3 and embedded in an Epon resin following a standard schedule. Ultrathin sections were stained with uranyl acetate and lead citrate.

Table 1. Data on 13 Patients With Idiopathic Dilated Cardiomyopathylegend

Morphometry, using a grid and point and counting system [13], was applied on histologic slides to assess the extent of myocardial fibrosis, and its prevalence was correlated with the degree of impairment of cardiac function (LV ejection fraction) and the myocardial content of TE.

A second correlative study was also performed on the myocardial content of the TE and the arrhythmic profile of each patient (Lown class) based on the results of Holter recordings (3 to 5 each patient) and/or electrocardiographic findings during hospital admissions. Needle muscle biopsies of vastus lateralis muscle were performed using a Bard Biopsy instrument with a 14-gauge needle as described [14] in patients with IDCM. Environmental exposure to heavy metals and toxic TE was assessed by means of a questionnaire.

Control samples for histology, morphometry and TE analysis were:

Group B: Left ventricular endomyocardial and thoracic muscle biopsy samples from 12 patients (eight male, four female mean age 53 ± 10 years) with valvular heart disease (mitral regurgitation in four patients aortic stenosis in three patients, aortic regurgitation in two patients, aortic stenosis and regurgitation in three patients) left ventricular dilation (left ventricular end-diastolic diameter [LVEDD] = 69.5 ± 7.48 mm) and depressed LV function (left ventricular ejection fraction [LVEF] = 30 ± 6.3%) obtained during the surgical replacement of the valve; left ventricular endomyocardial and thoracic muscle biopsies from 13 patients (10 male, three female, mean age 58.8 ± 9.7 years) with ischemic heart disease, LV dilation (LVEDD = 67.3 ± 4.8 mm) and LV dysfunction (LVEF = 33 ± 4%) taken at the time of coronary artery bypass surgery.

Group C. Papillary and thoracic muscular biopsies from 10 patients (five male, five female mean age 55.2 ± 8.6 years) with mitral stenosis and normal LV dimension (LVEDD = 48.2 ± 2.6 mm) and function (LVEF = 56.1 ± 4.4%) undergoing mitral valve replacement (control subjects).

Group D. Normal LV endomyocardial biopsies (section of specimens with normal histologic findings) from four patients (two male, two female, mean age 54 ± 4.5 years) who underwent a diagnostic cardiac catheterization with ventricular and coronary angiography because of chest pain, which showed normal coronary arteries, LV volumes and LV function. Moreover, in order that a uniform procedure was followed, biopsy specimens were taken from patients and control subjects using a Bipal Cordis bioptome.

Trace elements assessment

One ventricular biopsy specimen (weight range: 1.5 to 2.8 mg/wet weight) was processed to determine the levels of TE by neutron activation analysis [15]. The following elements were analyzed: silver (Ag), arsenic (As), gold, barium, calcium (CA), cadmium, cerium, cobalt, chromium, cesium, eruopium, iron, hafnium, mercury (Hg), iridium, lanthanum, lutetium, molibdenum, nickel, rubidium, antimony (Sb), scandium, selenium, samarium, tin, strontium, tantalum, terbium, thorium, uranium, ytterbium, zinc and zirconium.

When metallic surgical instruments are used to collect human tissue, metal contamination may occur, thus making it difficult to assess accurately the levels of ultratrace metal elements [16]. To reduce this bias as much as possible, surgical instruments made from a stainless-steel core covered by a film of titanium nitride (a very hard compound with a high chemical stability and very good wear resistance) were used. Samples were kept frozen until irradiation.

The observed values were compared with control samples and with data from the literature [17, 18 and 19].

Statistical analysis

Data were analyzed by means of SPSS/PC+ (Cary, North Carolina). Continuous data were summarized as mean ± SD. The difference between two groups was tested by Mann-Whitney U test. The relation between continuous variables was assessed by the method of the least squares. A two-tailed p value < 0.05 was considered significant.

Results

No cases of occupational exposure to TE were observed, not did any patients or control subjects come from heavily polluted geographic areas.

Clinical study

Echocardiography showed an increase of LVEDD (72.7 ± 4.9 mm) and a significant impairment of left ventricular function (LVEF = 28.5% ± 8.4%). No significant valvular abnormalities were present.

Holter monitoring revealed in all patients frequent ventricular ectopic beats with some couples and triplets and in six cases phases of nonsustained or sustained ventricular tachycardia (Lown class 4b) (Table 1). We performed a Holter monitoring also in control subjects with secondary cardiac dysfunction, which failed to show repetitive ventricular ectopic beats (Lown ≤3). Cardiac catheterization and left ventriculography confirmed the compromised global contractility with reduction of cardiac index and elevation of left ventricular filling pressure (Table 1). Coronary angiography showed a normal arteriogram in every case.

Histology of left ventricular biopsy fragments from each patient ruled out specific heart muscle diseases such as myocarditis, and storage or infiltrative heart muscle diseases, while showing signs of hypertrophy with attenuation and degenerative changes of myocardial fibers.

Electron microscopy showed degenerative changes to consist of loss of contractile elements, the presence of myelin bodies and the vacuolization of mitochondria with fragmentation of mitochondrial cristae.

Myocardial and muscle TE concentration

In the majority of cases, in both patients and control subjects, myocardial concentrations of Ca, cadmium, hafnium, iridium, lutetium, molibdenum, samarium, tin, strontium, tantalum, terbium, thorium, uranium, ytterbium and zirconium appeared to be below the lower analytical determination limit. In control subjects, concentrations of cerium, cesium, europium, nickel and scandium were below the determination limit. Mean concentration values of the remaining 13 elements in patients (groups A and and controls (group C) are shown in Table 2. The mean concentration of these TE was in the range of normal reference values [18] both in control subjects (group C) and in the four normal subjects (group D).

A severe increase in Hg and Sb was observed in IDCM patients (patients/control subjects ratio >10,000). In addition, Ag, As, gold, chromium, lanthanum and zinc levels were 10 to 250 times higher in patients than in control subjects. Trace elements concentrations in papillary muscle biopsies were within the normal range of variation.

In IDCM patients the mean concentrations were 178,400 ng/g for Hg, 19,260 ng/g for Sb and 625 ng/g for As, whereas corresponding values in normal control subjects were 8 ng/g, 1.5 ng/g and 2.5 ng/g respectively. In patients with specific forms of cardiac dysfunction the mean concentration of Hg was 30 ng/g in patients with valvular heart disease and 23 ng/g in patients with ischemic heart disease, of Sb was 6 ng/g and 6.5 ng/g and of As was 9.3 and 10.3 respectively (Table 2). Corresponding reference interval values in published reports were 5 to 480 ng/g for Hg, 2 to 35 ng/g for Sb and 4.4 to 14 ng/g for As in myocardial tissue [18].

Table 2. Mean Myocardial Trace Elements Concentration (ng/g) in Patients With Idiopathic Dilated Cardiomyopathy (Group A), Secondary Forms of Cardiac Dysfunction (Group , Control Subjects (Group C) and Normal Subjects (Group D) as Determined by Neutron Activation Analysislegend

The values given are well above the normal range. Moreover, the Hg soft tissue body burden of Hg in a reference man weighing 70 kg is estimated to be 13 mg, and the total body burden of Sb is about 1 mg [20]. In IDCM patients a simple calculation reveals up to 17.8 mg/100 g of heart tissue for Hg, and 1.9 mg/100 g for Sb, thus showing that these TE are stored abnormally in myocardial tissue.

No correlation was found between the concentrations of each TE and the age of the patient. The correlation coefficients between TE and age did not reach the statistical level of significance (correlation coefficients for Hg = 0.25, p = 0.42; for Sb = 0.26, p = 0.39).

No differences were observed in the levels of myocardial TE in male and female subjects (p = 0.44 for Hg; p = 0.76 for Sb).

The degree of myocardial fibrosis, assessed by microscopic examination of histologic fields, was mild to moderate (≤9.5%) and did not appear to be correlated with Hg or Sb concentrations (correlation coefficients for Hg = −0.03, p = 0.92; for Sb = −0.05, p = 0.87).

Patients with higher concentrations of myocardial TE appeared to have a more pronounced degree of LV impairment and electrical instability (see Table 1). Those with the most pronounced degree of LV impairment (LVEF <0.30) had higher average concentrations of Hg (279 vs. 61 ng/g, p = 0.03) and Sb (39.3 vs. 10.2 ng/g, p = 0.04) than those with partially preserved myocardial function (LVEF, between 0.30 and 0.49); patients with sustained and nonsustained ventricular tachycardia showed higher concentrations of TE than those without (Hg 324 vs. 54 ng/g, p = 0.0027; Sb 45.5 vs. 9,0 ng/g, p = 0.0043).

Skeletal muscle concentrations of the 32 TE examined were in the normal range in all patients and control subjects. In particular muscle concentration of Hg and Sb were <150 ng/g and <193 ng/g respectively [18].

Discussion

The most relevant result of our study is a large increase of the myocardial content of some TE in patients with IDCM not documented in patients with specific heart muscle disease presenting comparable degree of left ventricular dysfunction. This increase has an obvious statistical significance and its biologic significance needs to be evaluated.

Consideration on TE assessment

Most of the data reported in published reports on TE in human tissues are of limited value in the assessment of their toxicologic impact: this is due not only to individual biologic variations, but also to errors caused by analytic inconsistencies [21]. Patent discrepancies can be observed among studies conducted by spectrographic and neutron activation methods. Neutron activation analysis has been shown to be the most advantageous method for quantitative determination of TE in human tissues owning to its high level of precision, high specificity and high accuracy [22]. Particular attention has to be paid to preanalytic factors, such as ethnic variations, sampling, sample handling and storage.

Preanalytic factors on TE assessment

The range of values that we considered as normal for myocardial and muscular content of TE is argued from a review [18] of international published data on the elemental composition of human tissues of healthy, adult individuals from populations of different ethnicity. We can therefore postulate that these reference values were appropriate also for our population.

Moreover in our study both patients and control subjects were of the same geographic area and ethnicity (white Italian people) making unlikely that difference on TE concentration might be due to different genetic patterns.

Loss of water from small myocardial samples during analysis could lead to overestimation of the intramyocardial content of TE; evaporation could be as high as 50% of total weight. Data interpretation should, therefore, be cautious and doubled values should be regarded as normal. It would also take into account the biologic sources of variation. In autopsy studies, postmortem process and contamination of tissues by residual blood could lead to relatively high errors for several TE [23]; there is, however, no fear of this in our study.

Gender has not been proved to play a significant role in the distribution of TE [19], and, in agreement with the published data our study showed no significant gender differences in either IDCM patients or control subjects.

The body burden of most elements seems to be influenced significantly by age. Most TE are very low at birth and build up rapidly thereafter [24 and 25]; after the age of three months, however, such differences tend to disappear and, in some studies, no significant differences associated with age have been obtained [19]. The comparison of myocardial samples from young people (which we used as our control subjects) and adults may show slight differences in the levels of TE; an increase of three to four orders of magnitude, however, cannot depend on physiologic aging.

Another factor to consider is the anatomic distribution of TE. Differences in the levels of TE in different anatomic regions of the heart have been reported in animals [26, 27 and 28], but at present there is insufficient evidence to suggest that such a difference occurs in humans. No apparent differences were noted between the concentrations of TE in different parts of the ventricular myocardium [19].

Finally a direct or indirect effect of contrast medium on myocyte TE concentration can be taken into consideration. Indeed, surgical control samples showing normal TE values were obtained several days or weeks after catherization and angiography, whereas biopsy specimens of patients with IDCM were drawn right after the angiographic study. Nevertheless TE values observed in normal LV biopsies from four subjects undergoing an invasive study, including coronary and ventricular angiography, were found to be within normal limits. We can therefore reasonably rule out any effect, due either to TE contamination or to interference of iodine on the myocardial TE concentration.

In conclusion, the observed increase in the myocardial content of some TE is likely to reflect a pathologic phenomenon.

Side of myocardial TE increase

The increased concentrations of TE in the myocardium could depend on an increase of myocardial fibrous tissue, or an increase in endocellular concentrations of TE, or both. Morphometry, however, failed to show a correlation between the degree of myocardial fibrosis and the levels of TE. It seems, therefore, that myocardial accumulation of TE in IDCM should be mostly intracellular, which is in agreement with the extensive pathologic evidence that points to myocardial cell degeneration and dysfunction, rather than replacement of myocardiocytes by fibrous tissue, as the source of failure in IDCM.

Trace elements and ventricular arrhythmias

As far as the arrhythmic profile of our IDCM patients is concerned, a similar correlative trend was observed when comparing the severity of ventricular arrhythmias with myocardial concentrations of TE. Although the number of patients studied may not be representative, the incidence of ventricular tachycardia seems to be associated with higher values of TE (Table 1). In fact, in patients with Lown class 4b we found higher values of Ag and Sb than in patients with Lown class 2–3, and among these patients, No. 10 and No. 11, who showed episodes of sustained ventricular tachycardia on Holter monitoring, had the highest values. In patients with secondary forms of cardiac dysfunction and mild elevation of TE the Holter monitoring showed only a Lown class ≤3.

In summary, high increases of some TE in the myocardial tissue of patients with IDCM seem to correlate with the severity of cardiac impairment, as well as that of electrical instability.

Trace elements in IDCM compared with secondary cardiac dysfunction

In patients with valvular and ischemic cardiomyopathies having comparable degree of left ventricular dysfunction, only mild (≤5 times normal control subjects) increase of TE was documented. This point together with the absence of signs and/or symptoms of TE intoxication and the normal TE values observed on skeletal muscle biopsies suggest that myocardial TE accumulation is specifically correlated with the pathogenesis of IDCM itself.

Possible mechanism of TE accumulation in IDCM

Actually we are unable to explain its mechanism, as dilated cardiomyopathy remains an idiopathic entity. The more reliable, although unconfirmed, pathogenetic hypothesis for IDCM, is that of a virus-induced disease. It has been documented that a common viral (sackie virus) infection can change TE target organ distribution in mice with greatly increased accumulation of nickel [11], cadmium and mercury [12] in the wall of the ventricular myocardium. We can speculate that a cardiac viral infection might induce an impairment of cellular biomembranes, which could, in turn, increase the input or reduce the output of certain TE, determining toxic intracellular concentrations.

Potential consequences of TE accumulation in IDCM

At present, we are unable to establish the toxic threshold levels of TE in the myocardium, since biopsy data on patients with toxic TE exposure are not available. The extremely high values of Hg and Sb found in our patients with IDCM makes it unlikely that there would be no adverse effect. Indeed, each of the TE increased in IDCM myocardial tissue may interfere with cellular activities. Particularly heavy metals (i.e., Hg, Sb, Ag) whose values were the most elevated, are known to induce the formation of oxygen free radicals in the affected tissues [29, 30 and 31]. Superoxide anions and radicals can, in turn, inhibit cardiac sodium pump and several other ion transporters of the plasma membrane [32]. The final results may well be the idropic degeneration and the mitochondrial damage of myocardiocytes that are observed at histology and electron microscopy in IDCM.

Finally heavy metals can antagonize Ca++ at actin–myosin junction in a concentration-dependent way, producing a progressive decline of sarcomere contraction and thus of myocyte function. On pharmacologic grounds, drugs such as the inotropic agents that work on increasing intracellular Ca++ may find the reason of their inefficacy in dilated cardiomyopathy.

Conclusions

The accumulation of some TE seems to be a constant finding in IDCM but not in specific cardiomyopathies. This abnormality is limited to the myocardium and correlates with the severity of both heart failure and electrical instability. However, the mechanisms of the accumulation of TE and its consequence on myocyte structure and function need to be further elucidated.

References

1. Report of the 1995 WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Circulation 93 (1996), pp. 841–842.

2. A.L. Caforio, J.T. , E. Bonifacio et al., Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?. J Autoimmun 3 (1990), pp. 187–200. Abstract | Full Text + Links | PDF (1808 K) | View Record in Scopus | Cited By in Scopus (31)

3. C.J. Limas and C. Limas, Immune-mediated modulation of sarcoplasmic reticulum function in human dilated cardiomyopathy. Basic Res Cardiol 87 Suppl 1 (1992), pp. 269–276. View Record in Scopus | Cited By in Scopus (4)

4. E.G. Olsen, The pathogenesis of dilated cardiomyopathy. Postgrad Med J 68 Suppl 1 (1992), pp. S7–S10. View Record in Scopus | Cited By in Scopus (9)

5. T.H. Taha, P.K. Mazeika, C.M. Oakley and B. Maisch, Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients. Int J Cardiol 38 (1993), pp. 133–140. Abstract | Full Text + Links | PDF (891 K) | View Record in Scopus | Cited By in Scopus (2)

6. H.J. Why, B.T. Meany, P.J. et al., Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89 (1994), pp. 2582–2589. View Record in Scopus | Cited By in Scopus (106)

7. A.L. Caforio, P.J. Keeling, E. Zachara et al., Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344 (1994), pp. 773–777. Abstract | Full Text + Links | PDF (685 K) | View Record in Scopus | Cited By in Scopus (68)

8. V.V. Michels, P.P. Moll, F.A. et al., The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326 (1992), pp. 77–82.

9. D. McCall, Alcohol and the cardiovascular system. Curr Probl Cardiol 12 (1987), pp. 1–414.

10. W.C. Reeves, S.P. Marcuard, S.E. Willis and A. Movahed, Reversible cardiomyopathy due to selenium deficiency. J Parenter Enteral Nutr 13 (1989), pp. 663–665. View Record in Scopus | Cited By in Scopus (18)

11. N.G. Ilback, J. Fohlman and G. Friman, A common viral infection can change nickel target organ distribution. Toxicol Appl Pharmacol 114 (1992), pp. 166–170. Abstract | Full Text + Links | PDF (2279 K) | View Record in Scopus | Cited By in Scopus (6)

12. N.G. Ilback, U. Lindh, J. Fohlman and G. Friman, New aspects of murine sackie B3 myocarditis—focus on heavy metals. Eur Heart J 16 (1995), pp. 20–24. View Record in Scopus | Cited By in Scopus (20)

13. U. Brandrup and E.G.J. Olsen, Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. Br Med J 45 (1981), pp. 475–486.

14. A.M. Cotè, L. Jimenez, L.S. Adelman and T.L. Munsat, Needle muscle biopsy with the automatic Biopty instrument. Neurology 42 (1992), pp. 2212–2213. View Record in Scopus | Cited By in Scopus (13)

15. G. Nicolau, R. Pietra, E. Sabbioni, G. Mosconi, G. Cassina and P. Seghizzi, Multielement determination of metals in biological specimens of hard metal workers: a study carried out by Neutron Activation Analysis. J Trace Elem Electrolytes Health Dis 1 (1987), pp. 73–77.

16. R. Pietra, E. Sabbioni, F. Brossa, M. Gallorini, G. Faruffini and E.M. Fumagalli, Titanium nitride as a coating for surgical instruments used to collect human tissue for trace metal analysis. Analyst 115 (1990), pp. 1025–1028. View Record in Scopus | Cited By in Scopus (11)

17. T.G. Aalbers, J.P.W. Houtman and B. Makkink, Trace-element concentrations in human autopsy tissue. Clin Chem 32 (1987), pp. 2057–2064. View Record in Scopus | Cited By in Scopus (17)

18. G.V. Iyengar, W.E. Kollmer and H.J.M. BowenIn: The Elemental Composition of Human Tissues and Body Fluids Verlag Chemie, Weinheim, New York (1978), pp. 55–82.

19. P.O. Wester, Trace elements in heart tissue. Acta Med Scand Suppl 439 (1965), pp. 1–48. View Record in Scopus | Cited By in Scopus (2)

20. B.L. Carson, H.V. Ellis, III and J.L. McCannIn: Toxicology and Biological Monitoring of Metals in Humans , Chelsea (MI) (1986), pp. 21–46.

21. C. Minoia, R. Pietra, E. Sabbioni et al., Trace element reference values in tissues from inhabitants of the European Community. III. The control of preanalytical factors in the biomonitoring of trace elements in biological fluids. Sci Total Environ 120 (1992), pp. 63–79. Abstract | Full Text + Links | PDF (743 K) | View Record in Scopus | Cited By in Scopus (22)

22. B. Salbu and E. Steinnes, Applications of nuclear analytical techniques in environmental research. Plenary lecture. Analyst 117 (1992), pp. 243–249. View Record in Scopus | Cited By in Scopus (6)

23. T.G. Aalbers and J.P.W. Houtman, Relationships between trace elements and atherosclerosis. Sci Total Environ 43 (1985), pp. 255–283. Abstract | Full Text + Links | PDF (1518 K) | View Record in Scopus | Cited By in Scopus (16)

24. E. Vuori, A. Huunan-Seppala and J.O. Kilpio, Biologically active metals in human tissues. I—The effect of age and sex on the concentration of copper in aorta, heart, kidney, liver, lung, pancreas and skeletal muscle. Scand J Work Environ Health 4 (1978), pp. 167–175. View Record in Scopus | Cited By in Scopus (3)

25. E. Vuori, A. Huunan-Seppala and J.O. Kilpio, Biologically active metals in human tissues. II—The effect of age on the concentration of cadmium in aorta, heart, kidney, liver, lung, pancreas and skeletal muscle. Scand J Work Environ Health 5 (1979), pp. 16–22. View Record in Scopus | Cited By in Scopus (5)

26. J. Webb, K.A. Kirk, W. Niedermeier, J.H. Griggs, M.E. and T.N. , Distribution of 8 trace metals in beef heart tissue. Bioinorg Chem 5 (1976), pp. 253–259. Abstract | Abstract + References | PDF (393 K) | View Record in Scopus | Cited By in Scopus (1)

27. J. Webb, K.A. Kirk, W. Niedermeier, J.H. Griggs, M.E. and T.N. , Use of pattern recognition to classify beef cardiovascular tissues on the basis of their trace metal compositions. Bioinorg Chem 5 (1976), pp. 261–266. Abstract | Abstract + References | PDF (347 K) | View Record in Scopus | Cited By in Scopus (1)

28. J. Webb, K.A. Kirk, W. Niedermeier, J.H. Griggs, M.E. and T.N. , Distribution of 9 trace metals in 17 anatomic sites of dog heart tissue and their classification using pattern recognition. Bioinorg Chem 7 (1977), pp. 303–314. Abstract | Abstract + References | PDF (706 K) | View Record in Scopus | Cited By in Scopus (2)

29. M. Chevion, Protection against free radical-induced and transition metal-mediated damage: the use of “pull†and “push†mechanisms. Free Radic Res Commun 12/13 (1991), pp. 691–696. View Record in Scopus | Cited By in Scopus (32)

30. C. Coudray, F. Boucher, M.J. , J. Arnaud, J. De Leiris and A. Favier, Zinc deficiency, ethanol, and myocardial ischemia affect lipoperoxidation in rats. Biol Trace Elem Res 30 (1991), pp. 103–118. View Record in Scopus | Cited By in Scopus (24)

31. M.A. Tirmenstein, P.I. Plews, C.V. , M.D. Woolery, H.E. Wey and M.A. Toraason, Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes. Toxicol Appl Pharmacol 130 (1995), pp. 41–47. Abstract | PDF (637 K) | View Record in Scopus | Cited By in Scopus (21)

32. Xie ZJ, Wang YH, Askari A, Huang WH, Klaunig JE, Askari A. Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. J Mol Cell Cardiol 1990;22:911–20..

Address correspondence and reprint requests: Frustaci, MD, Department of Cardiology, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy

Journal of the American College of Cardiology Volume 33, Issue 6, May 1999, Pages 1578-1583

Home

Browse

My Settings

Alerts

Help

About ScienceDirect | Contact Us | Terms & Conditions | Privacy Policy

Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.